Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dermatology
Biotech
Incyte, fresh off gaining MorphoSys drug, buys Escient for $750M
Incyte is dolloping another deal onto its 2024 partnership plate, buying San Diego-based Escient Pharmaceuticals for $750 million.
Max Bayer
Apr 23, 2024 10:43am
Oruka spins out of Paragon with assets, public listing and cash
Apr 3, 2024 7:30am
Almirall signs yes-nonsense deal with Eloxx for $3M upfront
Mar 13, 2024 10:31am
Lilly's lebrikizumab clears eczema in people with skin of color
Mar 11, 2024 9:24am
Incyte's oral Dupixent rival hits in midphase skin disease trial
Mar 11, 2024 7:16am
Medicxi merges 6 dermatology biotechs into one, adds $100M
Feb 11, 2024 7:00pm